Reproductive BioMedicine Online
Volume 21, Issue 3 , Pages 331-337 , September 2010

High serum oestradiol concentrations in IVF cycles increase the risk of pregnancy complications related to abnormal placentation

Received 8 December 2009 ,Revised 9 April 2010 ,Accepted 13 April 2010.

References 

  1. Chen QJ, Sun XX, Li L, et al. Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH). Acta. Obstet. Gynecol. Scand. 2007;86:849–854
  2. De Ziegler D, Fanchin R, de Moustier B, et al. The hormonal control of endometrial receptivity: estrogen (E2) and progesterone. J. Reprod. Immunol. 1998;39:149–166
  3. Devroey P, Bourgain C, Macklon NS, et al. Reproductive biology and IVF: ovarian stimulation and endometrial receptivity. Trends Endocrinol. Metab. 2004;15:84–90
  4. Forman R, Fries N, Testart J, et al. Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation. Fertil. Steril. 1988;49:118–122
  5. Gelety TJ, Buyalos RP. The influence of supraphysiologic estradiol levels on human nidation. J. Assis. Reprod. Genet. 1995;12:406–412
  6. Healy DL, Breheny S, Halliday J, et al. Prevalence and risk factors for obstetric haemorrhage in 6730 singleton pregnancies after assisted reproductive technology in Victoria Australia. Hum. Reprod. 2009;(Online publication ahead of print)
  7. Horcajadas JA, Díaz-Gimeno P, Pellicer A, et al. Uterine receptivity and the ramifications of ovarian stimulation on endometrial function. Semin. Reprod. Med. 2007;25:454–460
  8. Levi AJ, Drews MR, Bergh PA, et al. Controlled ovarian hyperstimulation does not adversely affect endometrial receptivity in in vitro fertilization cycles. Fertil. Steril. 2001;76:670–674
  9. McLean-Morris J, Van Wagenen G. Interception (the use of postovulatory estrogens to prevent implantation). Am. J. Obstet. Gynecol. 1973;115:101–106
  10. Nikas G, Develioglu OH, Toner JP, et al. Endometrial pinopodes indicate a shift in the window of receptivity in IVF cycles. Hum Reprod. 1999;14:787–792
  11. Norwitz ER. Defective implantation and placentation: laying the blueprint for pregnancy complications. Reprod. Biomed. Online. 2006;13:591–599
  12. Sharara FI, McClamrock HD. High estradiol levels and high oocyte yield are not detrimental to in vitro fertilization outcome. Fertil. Steril. 1999;72:401–405
  13. Simon C, Cano F, Valbuena D, et al. Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum. Reprod. 1995;10:2432–2437
  14. Staessen C, Camus M, Bollen N, Devroey P, Van-Steirteghem AC. The relationship between embryo quality and the occurrence of multiple pregnancies. Fertil. Steril. 1992;3:626–630
  15. Testart J, Belaisch-Allart J, Forman R, et al. Influence of different stimulation treatments on oocyte characteristics and in-vitro fertilizing ability. Hum. Reprod. 1989;4:92–97
  16. Van Santen MR, Haspels AA, Heijnen HF, et al. Interfering with implantation by postcoital estrogen administration. II. Endometrium epithelial cell ultrastructure. Contraception. 1988;38:711–724
  17. Yu Ng EH, Yeung WS, Yee Lan Lau E, et al. High serum oestradiol concentrations in fresh IVF cycles do not impair implantation and pregnancy rates in subsequent frozen-thawed embryo transfer cycles. Hum. Reprod. 2000;15:250–255

 Jacob Farhi received his MD from the Tel Aviv University in 1987. He is a senior lecturer at the Sackler School of Medicine, Tel Aviv University. He works as a senior consultant physician in the IVF and Infertility Unit at the Rabin Medical Centre. Currently his research interests are in the fields of follicular regulation in the human fetal ovaries and in clinical aspects of ovulation induction, IVF and in-vitro maturation treatments.

PII: S1472-6483(10)00234-8

doi: 10.1016/j.rbmo.2010.04.022

Reproductive BioMedicine Online
Volume 21, Issue 3 , Pages 331-337 , September 2010

Article Tools

* Image Usage & Resolution